# Heart Rate Regularization in Atrial Fibrilation and Heart Failure

Study · id `cardio:ct-nct05029570` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05029570](<https://clinicaltrials.gov/study/NCT05029570>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05029570

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 334 participants.

## Technical summary

Registry record NCT05029570. Randomized; single masking; primary purpose treatment. Start 2022-04-29 (actual); primary completion 2030-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 334 participants (planned count; ClinicalTrials.gov record NCT05029570, source copy `cardio:ctgov-nct05029570-2025-09-09`, retrieved 2026-10-26)
- Started: 2022-04-29 (actual) (ClinicalTrials.gov record NCT05029570, source copy `cardio:ctgov-nct05029570-2025-09-09`, retrieved 2026-10-26)
- Primary completion: 2030-07-31 (anticipated) (ClinicalTrials.gov record NCT05029570, source copy `cardio:ctgov-nct05029570-2025-09-09`, retrieved 2026-10-26)
- Completion: 2030-09 (anticipated) (ClinicalTrials.gov record NCT05029570, source copy `cardio:ctgov-nct05029570-2025-09-09`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT05029570, source copy `cardio:ctgov-nct05029570-2025-09-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05029570-2025-09-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Heart Rate Regularization in Atrial Fibrilation and Heart Failure
- Acronym: PACE-FIB
- Condition: Heart Failure
- Condition: Atrial Fibrillation
- Intervention (Device): Conduction System Pacing (pacemaker implantation)
- Lead sponsor: Daniel Rodríguez Muñoz
- Lead sponsor class: OTHER
- Collaborator: Sociedad Castellana de Cardiologia
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 6ae945d450d78ad23c0c0c8995e29889e0543a829a609f87ec509368e8f07a4c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
